OR WAIT null SECS
© 2021 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
October 18, 2021
Seqirus’s FLUCELVAX® cell-based quadrivalent influenza vaccine has been approved to expand the age indication to children as young as 6 months of age by the US Food and Drug Administration.
September 20, 2021
Initial results from the trial indicate it was well-tolerated and promoted a good immune response.
September 14, 2021
Anthony S. Fauci, MD, Director of the National Institute of Allergy and Infectious Disease, reveals when he believes a COVID-19 vaccine for children aged less than 12 years will be available.
September 07, 2021
The American Academy of Pediatrics (AAP) has issued its recommendations for the upcoming influenza season, including guidance on administering the vaccine to patients with COVID-19.
August 26, 2021
Although the vaccine rollout has snagged, the effort has already saved thousands.
August 25, 2021
Merck has released promising topline results from their study of VAXNEUVANCE™, a 15-valent pneumococcal conjugate vaccine, in infants.
August 23, 2021
Faced with the fourth highest vaccine exemption rate, Michigan began requiring an education session before a parent could get a nonmedical exemption. Did it lead to an improvement?
Today’s vaccine approval opens up the ability to administer it off-label to children aged younger than 11 years. A statement from the American Academy of Pediatrics (AAP) discourages doing so.
August 11, 2021
For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.
July 29, 2021
Patient portals can be a powerful communication tool for both clinician and family, but can they also be used to improve uptake of the annual influenza vaccine?